Kadcyla Logo
Sept. 7, 2024
What is KADCYLA® (ado-trastuzumab emtansine) for MBC? KADCYLA® (ado-trastuzumab emtansine) in HER2+ Breast Cancer ImmunoGen Announces Sale of Residual Kadcyla Royalties | Business Wire Kadcyla Logo
Sept. 7, 2024
What is KADCYLA® (ado-trastuzumab emtansine) for MBC? KADCYLA® (ado-trastuzumab emtansine) in HER2+ Breast Cancer ImmunoGen Announces Sale of Residual Kadcyla Royalties | Business Wire Kadcyla Logo